David J. Araten

1.6k total citations
40 papers, 1.1k citations indexed

About

David J. Araten is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, David J. Araten has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 20 papers in Hematology and 15 papers in Genetics. Recurrent topics in David J. Araten's work include Complement system in diseases (25 papers), Renal Diseases and Glomerulopathies (11 papers) and Blood groups and transfusion (9 papers). David J. Araten is often cited by papers focused on Complement system in diseases (25 papers), Renal Diseases and Glomerulopathies (11 papers) and Blood groups and transfusion (9 papers). David J. Araten collaborates with scholars based in United States, Italy and United Kingdom. David J. Araten's co-authors include Lucio Luzzatto, Khédoudja Nafa, Rosario Notaro, Howard T. Thaler, Anastasios Karadimitris, Lucia Gargiulo, David W. Golde, Rong H. Zhang, Amanda Wilson and Alexander Röth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

In The Last Decade

David J. Araten

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Araten United States 16 698 424 353 281 226 40 1.1k
Guibin Chen United States 15 526 0.8× 516 1.2× 86 0.2× 157 0.6× 173 0.8× 31 887
Akira Miyazato Japan 16 338 0.5× 338 0.8× 36 0.1× 160 0.6× 359 1.6× 22 883
Elisabeth T Korthof Netherlands 13 208 0.3× 605 1.4× 21 0.1× 143 0.5× 383 1.7× 18 1.1k
Sumithira Vasu United States 16 316 0.5× 355 0.8× 48 0.1× 82 0.3× 251 1.1× 49 700
Alexander J. Cole Australia 14 184 0.3× 53 0.1× 70 0.2× 53 0.2× 357 1.6× 31 775
Guillermo Dighiero Uruguay 11 793 1.1× 235 0.6× 14 0.0× 1.3k 4.7× 303 1.3× 15 1.7k
Simon Le Gallou France 14 551 0.8× 182 0.4× 41 0.1× 136 0.5× 158 0.7× 23 896
H van Kamp Netherlands 15 159 0.2× 483 1.1× 27 0.1× 146 0.5× 266 1.2× 25 883
Chiara Gentilini Germany 14 605 0.9× 252 0.6× 22 0.1× 99 0.4× 177 0.8× 24 932
Fengmei Wang China 13 296 0.4× 52 0.1× 148 0.4× 47 0.2× 87 0.4× 35 579

Countries citing papers authored by David J. Araten

Since Specialization
Citations

This map shows the geographic impact of David J. Araten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Araten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Araten more than expected).

Fields of papers citing papers by David J. Araten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Araten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Araten. The network helps show where David J. Araten may publish in the future.

Co-authorship network of co-authors of David J. Araten

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Araten. A scholar is included among the top collaborators of David J. Araten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Araten. David J. Araten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kulasekararaj, Austin, Axel Glasmacher, Jeff Szer, et al.. (2022). Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria. European Journal Of Haematology. 108(5). 391–402. 5 indexed citations
3.
4.
Schrezenmeier, Hubert, Alexander Röth, David J. Araten, et al.. (2020). Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry. Annals of Hematology. 99(7). 1505–1514. 94 indexed citations
5.
Milam, Emily C., Kathryn J. Martires, Kristen I. Lo Sicco, David J. Araten, & Andrew G. Franks. (2019). A patient with POEMS syndrome responding to modified CyBorD chemotherapy as a bridge to autologous stem cell transplantation. JAAD Case Reports. 5(3). 228–230. 1 indexed citations
6.
Lobry, Camille, et al.. (2019). Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH). Experimental Hematology and Oncology. 8(1). 17–17. 2 indexed citations
7.
Araten, David J., et al.. (2019). Analysis of platelets by flow cytometry in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH). Blood Cells Molecules and Diseases. 80. 102372–102372. 4 indexed citations
8.
Araten, David J., et al.. (2019). Symptomatic Bilirubin Gallstones in Patients with PNH Treated with Eculizumab. Blood. 134(Supplement_1). 4795–4795. 2 indexed citations
9.
Evensen, Nikki A., Julia Meyer, David J. Araten, et al.. (2018). MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia. Haematologica. 103(5). 830–839. 28 indexed citations
10.
Araten, David J., Anna Paola Iori, Karen T. Brown, et al.. (2014). Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria. Journal of Hematology & Oncology. 7(1). 27–27. 13 indexed citations
11.
Araten, David J., et al.. (2012). Leukemic Blasts with the Paroxysmal Nocturnal Hemoglobinuria Phenotype in Children with Acute Lymphoblastic Leukemia. American Journal Of Pathology. 181(5). 1862–1869. 4 indexed citations
12.
Araten, David J., Rosario Notaro, Howard T. Thaler, et al.. (2011). Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature. Haematologica. 97(3). 344–352. 20 indexed citations
13.
Curran, Kevin J., Nancy A. Kernan, Susan E. Prockop, et al.. (2011). Paroxysmal nocturnal hemoglobinuria in pediatric patients. Pediatric Blood & Cancer. 59(3). 525–529. 31 indexed citations
14.
Araten, David J., et al.. (2006). The PIG-A Gene Is Hypermutable in Lymphoid Neoplasms.. Blood. 108(11). 2395–2395. 1 indexed citations
15.
Araten, David J., David W. Golde, Rong H. Zhang, et al.. (2005). A Quantitative Measurement of the Human Somatic Mutation Rate. Cancer Research. 65(18). 8111–8117. 126 indexed citations
16.
Thaler, Howard T., Lucio Luzzatto, & David J. Araten. (2004). High incidence of thrombosis in African-American and Latin-American patients with Paroxysmal Nocturnal Haemoglobinuria. Thrombosis and Haemostasis. 93(1). 88–91. 39 indexed citations
17.
Karadimitris, Anastasios, Ke Li, Rosario Notaro, et al.. (2001). Association of clonal T‐cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH. British Journal of Haematology. 115(4). 1010–1014. 41 indexed citations
18.
Araten, David J., David Swirsky, Anastasios Karadimitris, et al.. (2001). Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria. British Journal of Haematology. 115(2). 360–368. 34 indexed citations
19.
Karadimitris, Anastasios, John S. Manavalan, Howard T. Thaler, et al.. (2000). Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood. 96(7). 2613–2620. 96 indexed citations
20.
Araten, David J., Trebor Lawton, James L.M. Ferrara, et al.. (1993). IN VITRO ALLOREACTIVITY AGAINST HOST ANTIGENS IN AN ADULT HLA-MISMATCHED BONE MARROW TRANSPLANT RECIPIENT DESPITE IN VIVO HOST TOLERANCE. Transplantation. 55(1). 76–82. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guibin Chen Breakdown of academic impact, for papers by Akira Miyazato Breakdown of academic impact, for papers by Elisabeth T Korthof Breakdown of academic impact, for papers by Sumithira Vasu Breakdown of academic impact, for papers by Alexander J. Cole Breakdown of academic impact, for papers by Guillermo Dighiero Breakdown of academic impact, for papers by Simon Le Gallou Breakdown of academic impact, for papers by H van Kamp Breakdown of academic impact, for papers by Chiara Gentilini Breakdown of academic impact, for papers by Fengmei Wang
Rankless by CCL
2026